KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $143,000 | +19.2% | 23,263 | +13.2% | 0.00% | – |
| Q4 2016 | $120,000 | -90.1% | 20,545 | -91.0% | 0.00% | – |
| Q3 2016 | $1,213,000 | +840.3% | 228,490 | +1074.5% | 0.00% | – |
| Q2 2016 | $129,000 | -96.1% | 19,454 | -97.9% | 0.00% | -100.0% |
| Q3 2015 | $3,285,000 | -78.2% | 933,215 | -38.2% | 0.00% | -83.3% |
| Q2 2015 | $15,067,000 | +24.8% | 1,509,804 | +59.2% | 0.01% | +20.0% |
| Q1 2015 | $12,071,000 | -10.0% | 948,182 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $13,416,000 | +2.9% | 948,182 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $13,038,000 | -10.6% | 948,182 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $14,583,000 | -48.3% | 948,182 | -42.7% | 0.01% | -45.5% |
| Q1 2014 | $28,192,000 | +53.3% | 1,654,443 | +16.5% | 0.01% | +57.1% |
| Q4 2013 | $18,389,000 | +56.4% | 1,419,947 | +21.8% | 0.01% | +40.0% |
| Q3 2013 | $11,759,000 | +79.8% | 1,165,412 | +33.1% | 0.01% | +66.7% |
| Q2 2013 | $6,539,000 | – | 875,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |